Latest Headlines

  1. OGT Pushes Forward Hybridisation-Based Targeted Sequencing

    Oxford Gene Technology (OGT), The Molecular Genetics Company, has made several advances in hybridisation-based target enrichment protocols that now enable researchers to prepare samples for sequencing in just one day

  2. SCIEX Announces The First FDA-Cleared Vitamin D Assay Kit For Mass Spectrometry

    SCIEX Diagnostics, the in vitro diagnostics division of SCIEX, a global leader in mass spectrometry in the life sciences industry, announced recently the first and only FDA-cleared (via the de novo pathway) LC-MS based Vitamin D assay kit, the Vitamin D 200M Assay, exclusively for the SCIEX Topaz System

  3. Prescient Medicine Hosting Opioid Summit In Philadelphia June 20

    Prescient Medicine, a leader in Precision Medicine and pharmacogenetics, is pleased to host its first-ever 2017 Opioid Summit, "SOS: SOLVING THE OPIOID CRISIS Through a Cross-Functional Partnership," June 20 in Philadelphia, Pa. at the Union League Club, 9 a.m. – 3:30 p.m

  4. Inovio HIV Vaccine Elicits Nearly 100% Immune Response Rates In A Clinical Study

    Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today announced that its HIV vaccine, PENNVAX®-GP, produced amongst the highest overall levels of immune response rates (cellular and humoral) ever demonstrated in a human study by an HIV vaccine.

  5. Circulogene Expands Liquid Biopsy Testing Capabilities, Adds Three cfRNA-Based NSCLC Tests Supporting Personalized Treatment For Lung Cancer Patients

    Circulogene has announced the addition of three new cfRNA-based tests to its liquid biopsy testing capabilities. The new cfRNA additions include testing for ALK and ROS1 gene fusions and PD-L1 expression – associated with non-small cell lung cancer (NSCLC) – enabling actionable, targeted NSCLC treatment

  6. Lab7 Systems Announces High-Performance Cloud For Genomic-Scale Data Management Built On IBM Cloud

    Lab7 Systems, Inc., a leader in laboratory workflow management for data-intensive life science applications, announces the Lab7 High-Performance Genomic Cloud powered by IBM, a complete solution for the management and analysis of genomic-scale data workloads and lab operations

  7. Geneious Biologics To Power Better Biological Drug Development

    Geneious Biologics, an enterprise software solution for screening antibodies and related constructs using sequence data, was launched recently and will change the way scientists identify antibodies for use in biological drug development

  8. LabCorp Exclusively Launches Sera Prognostics’ PreTRM Test To Assess For Risk Of Preterm Birth

    LabCorp recently announced the nationwide availability of the PreTRM test. Developed by Sera Prognostics, Inc., the PreTRM test is the first of its kind validated blood test that provides an early and individualized prediction of preterm birth risk for pregnant women

  9. CLJI Worldwide Trial Enrolls First Patient In Clinical Study Evaluating The Performance Of VIBLOK As A Barrier For Herpes Simplex Virus Transmission In Men And Women

    CLJI Worldwide reports the start of the VIBLOK Safety And perFormancE Trial (SAFE Trial)

  10. New Weighing Equipment Helps Pharmaceutical Company Pass The Audit Risk-Based Process Verification

    For more than 200 years, the German-based company Klosterfrau Healthcare Group has been developing, manufacturing and selling pharmaceutical products